After a v-shape recovery, the ASX is now back within reach of last year’s market highs. However, all might not be as rosy as it seems, with the February reporting season set to uncover businesses whose Financial Health has been propped up by Government stimulus and capital raisings.
In this webinar recording, Head of Research, Kien Trinh, and Business Development Manager, Mat Potts, explore the risks and opportunities from the reporting season and how you can back winning stocks with Stock Doctor. Australia’s premier DIY share investing platform has helped our members achieve their financial goals with our Star Growth Stocks returning a remarkable 17.9% p.a.* since 1995.
* Performance figure for Star Growth Stocks is from 01/09/1995 – 31/01/2021. This is the average annualised investment performance for each notional portfolio of stocks (based on actual changes in Star Stock recommendations) over the period shown taking into account capital returns, dividend income and estimated transaction costs (but not other distributions, fees, charges or tax) and using various assumptions including assumptions regarding dividend reinvestment and portfolio rebalancing after changes are made to the notional portfolio. These past performance figures are not a reliable indicator of future performance of the notional portfolio, or any stocks included in the portfolio. Investment performance of the notional portfolio over shorter periods will vary. You should not make investment decisions based on performance figures alone. For more detailed information about how these figures are calculated, including the assumptions used, click here.
To discuss the future of your investments in detail, book in a free consultation with a Lincoln representative.
To discuss the future of your investments in detail, book in a free consultation with a Lincoln financial expert.